File Download
 
 
Supplementary

Conference Paper: 48 weeks pegylated interferon alfa-2a is superior to 24 weeks of pegylated interferon alfa-2b in achieving HBeAg seroconversion in chronic hepatitis B infection (Abstract)
  • Basic View
  • Metadata View
  • XML View
Title48 weeks pegylated interferon alfa-2a is superior to 24 weeks of pegylated interferon alfa-2b in achieving HBeAg seroconversion in chronic hepatitis B infection (Abstract)
 
AuthorsLai, LSW
Fung, TT
Lai, ST
Yiu, J
Lam, P
Zhang, H
Wong, WM
Lo, CM
Fan, ST
Hui, CK
Leung, N
Lau, G
 
Issue Date2006
 
CitationShanghai-Hong Kong International Liver Congress 2006, Shanghai, China, 25-28 March 2006. Journal of Gastroenterology and Hepatology, v. 21 n. Suppl 2, p. A90 [How to Cite?]
 
DC FieldValue
dc.contributor.authorLai, LSW
 
dc.contributor.authorFung, TT
 
dc.contributor.authorLai, ST
 
dc.contributor.authorYiu, J
 
dc.contributor.authorLam, P
 
dc.contributor.authorZhang, H
 
dc.contributor.authorWong, WM
 
dc.contributor.authorLo, CM
 
dc.contributor.authorFan, ST
 
dc.contributor.authorHui, CK
 
dc.contributor.authorLeung, N
 
dc.contributor.authorLau, G
 
dc.date.accessioned2010-09-26T00:22:12Z
 
dc.date.available2010-09-26T00:22:12Z
 
dc.date.issued2006
 
dc.identifier.citationShanghai-Hong Kong International Liver Congress 2006, Shanghai, China, 25-28 March 2006. Journal of Gastroenterology and Hepatology, v. 21 n. Suppl 2, p. A90 [How to Cite?]
 
dc.identifier.hkuros117040
 
dc.identifier.issueSuppl 2
 
dc.identifier.spage90
 
dc.identifier.urihttp://hdl.handle.net/10722/108022
 
dc.identifier.volume, v. 21 n. Suppl 2
 
dc.languageeng
 
dc.relation.ispartofShanghai-Hong Kong International Liver Congress 2006, Shanghai, China, 25-28 March 2006. Journal of Gastroenterology and Hepatology
 
dc.title48 weeks pegylated interferon alfa-2a is superior to 24 weeks of pegylated interferon alfa-2b in achieving HBeAg seroconversion in chronic hepatitis B infection (Abstract)
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Lai, LSW</contributor.author>
<contributor.author>Fung, TT</contributor.author>
<contributor.author>Lai, ST</contributor.author>
<contributor.author>Yiu, J</contributor.author>
<contributor.author>Lam, P</contributor.author>
<contributor.author>Zhang, H</contributor.author>
<contributor.author>Wong, WM</contributor.author>
<contributor.author>Lo, CM</contributor.author>
<contributor.author>Fan, ST</contributor.author>
<contributor.author>Hui, CK</contributor.author>
<contributor.author>Leung, N</contributor.author>
<contributor.author>Lau, G</contributor.author>
<date.accessioned>2010-09-26T00:22:12Z</date.accessioned>
<date.available>2010-09-26T00:22:12Z</date.available>
<date.issued>2006</date.issued>
<identifier.citation>Shanghai-Hong Kong International Liver Congress 2006, Shanghai, China, 25-28 March 2006. Journal of Gastroenterology and Hepatology, v. 21 n. Suppl 2, p. A90</identifier.citation>
<identifier.uri>http://hdl.handle.net/10722/108022</identifier.uri>
<language>eng</language>
<relation.ispartof>Shanghai-Hong Kong International Liver Congress 2006, Shanghai, China, 25-28 March 2006. Journal of Gastroenterology and Hepatology</relation.ispartof>
<title>48 weeks pegylated interferon alfa-2a is superior to 24 weeks of pegylated interferon alfa-2b in achieving HBeAg seroconversion in chronic hepatitis B infection (Abstract)</title>
<type>Conference_Paper</type>
<identifier.hkuros>117040</identifier.hkuros>
<identifier.volume>, v. 21 n. Suppl 2</identifier.volume>
<identifier.issue>Suppl 2</identifier.issue>
<identifier.spage>90</identifier.spage>
</item>